Profit Margin (Quarterly) Chart

View Profit Margin (Quarterly) for GRRMF.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Profit Margin (Quarterly) Chart
Start Trial

Historical Profit Margin (Quarterly) Data

View and export this data back to 2007. Start Trial.
Date Value
November 30, 2025 -47.94%
August 31, 2025 -2.19%
May 31, 2025 2.93%
February 28, 2025 -3.36%
November 30, 2024 6.73%
August 31, 2024 5.55%
May 31, 2024 6.56%
February 29, 2024 2.88%
November 30, 2023 7.76%
August 31, 2023 5.89%
May 31, 2023 7.12%
February 28, 2023 2.94%
November 30, 2022 6.57%
August 31, 2022 6.14%
May 31, 2022 6.01%
February 28, 2022 3.16%
November 30, 2021 6.51%
August 31, 2021 5.30%
May 31, 2021 7.66%
February 28, 2021 3.21%
November 30, 2020 7.58%
August 31, 2020 7.34%
May 31, 2020 8.13%
February 29, 2020 1.39%
November 30, 2019 -22.47%
Date Value
August 31, 2019 5.31%
May 31, 2019 13.22%
February 28, 2019 32.19%
November 30, 2018 11.17%
August 31, 2018 5.36%
May 31, 2018 5.80%
February 28, 2018 16.95%
November 30, 2017 10.26%
August 31, 2017 7.92%
May 31, 2017 7.38%
February 28, 2017 4.39%
November 30, 2016 8.25%
August 31, 2016 8.93%
May 31, 2016 8.33%
February 29, 2016 5.06%
November 30, 2015 15.33%
August 31, 2015 5.86%
May 31, 2015 6.28%
February 28, 2015 4.19%
November 30, 2014 6.56%
August 31, 2014 6.13%
May 31, 2014 6.21%
February 28, 2014 3.46%
November 30, 2013 8.14%
August 31, 2013 6.17%

Profit Margin Definition

Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.

Read full definition.

Profit Margin (Quarterly) Range, Past 5 Years

View Profit Margin (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Profit Margin (Quarterly) Benchmarks

View Profit Margin (Quarterly) Benchmarks
Start Trial
Sartorius AG 10.17%
SCHOTT Pharma AG & Co. KGaA 13.83%
Agilent Technologies, Inc. 18.47%
Bio-Rad Laboratories, Inc. 57.05%
Bruker Corp. -6.07%